Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

35.42
Delayed Data
As of May 04
 +0.31 / +0.88%
Today’s Change
30.13
Today|||52-Week Range
52.58
-30.34%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.50, with a high estimate of 47.00 and a low estimate of 35.00. The median estimate represents a +17.17% increase from the last price of 35.42.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.74
Sales
$62.9M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.40%
 
 
 
 
 
 
Growthannually 197.36%
 
 
 
 
 

Sales

Growthquarterly -18.86%
 
 
 
 
 
 
Growthannually 319.27%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account